Frank Lang Email & Phone Number

Garden Grove, California, United States

Greater Los Angeles Area

· Responsible for marketing IVIg and SCIg in the Greater Los Angeles area including Los Angeles, Ventura, Santa Barbara and Kern Counties· Develop and increase referral sources for IVIg with focus on Neurology, Immunology, Rheumatology and Hematology/Oncology· Responsible for relaunching Coag program regionally in CA and marketing service capabilities to the HTC’s· Provide Coag and Bleeding Disorders training and support to sales team and new hires

Greater Los Angeles Area

• Responsible for marketing Coram’s specialty infusion capabilities including IVIG,SUB Q IG and Alpha 1 Augmentation in the Greater Los Angeles area andNorthern CA• Generated over $10 Million in specialty sales out of the 4 markets/branches- IVIGand SUB Q accounting for over 85% of the total revenue• Establish relationships and work closely with manufacturers of specialty therapies to drive referrals to home and the ambulatory infusion suites (AIS)• Develop specialty selling market strategy and coordinate with local Territory Managers to ensure execution and pull-through• Train and work with to develop and increase referral sources for IVIG with focus on Neurology, Rheumatology, Immunology and Hematology/Oncology

• Generated $1.7 Million in additional AIS revenue in first 9 months and $6.8 Million the 2nd Year or 360% Increase Year over Year• Responsible for revenue of 15 ambulatory infusion suites in Western Region (CA, OR, WA, NV, ID, UT)• Train Coram branch and sales teams to recognize AIS opportunities, promote the AIS and direct referrals when appropriate• Market all potential AIS referral sources with focus on physician specialists (Hematology/Oncology, Neurology, Rheumatology, Dermatology, Gastroenterology) and existing infusion centers

Greater Los Angeles Area

• Exceeded quarterly and yearly sales target all 4 years (No. 1 in BDS Division)• Responsible for marketing Coram’s IVIG program and Hemophilia Services throughout CA, AZ, NV and Hawaii and generating yearly net sales of $30 Million• Established Disease State Management program and specialty pharmacy pricing with large payors to increase pull-through and assure patient retention• Working with Hemophilia Treatment Centers, Manufacturers and Hemophilia Foundations to facilitate care and support for patients• Coordinate and present CEU programs and in-services with medical providers and payors